IN THE NEWS

« Previous Release | Next Release »

BOTHELL, Wash., -- Cardiac Science Corporation, a global leader in AED, ECG, cardiac stress test, cardiac rehab, and Holter devices that connect to EMR and HIS systems, announced today that it completed certification for its HeartCentrix (R) ECG connectivity software with Sage Intergy EHR electronic health records system. Sage is a leading developer and provider of computer-based practice management and electronic medical record (EMR) systems for medical group practices and healthcare systems.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)

Sage healthcare products are used by tens of thousands of clients nationwide and accommodate the work style and clinical approach of every physician in a practice. Sage's current and future Intergy clients will be readily able to communicate with HeartCentrix connectivity software from Cardiac Science, pulling data directly from monitoring devices into the electronic health record. Similarly, Cardiac Science's customers can choose Sage as their EMR partner and be assured the patient information will flow smoothly into the health record.

Designed to communicate seamlessly with EMR software, HeartCentrix solutions help streamline workflow in multiple healthcare environments. HeartCentrix - which enables seamless data transfer from Burdick(R) and Quinton(R) brand electrocardiograph (EKG) devices, cardiac stress, and Holter monitoring devices to physician EMR software - can be installed with a new Sage Intergy EHR implementation or into an existing Intergy system.

"The physician today demands solutions that improve office workflow efficiencies, support the sharing of patient data between multiple systems, and enable the movement of patient test results across the healthcare continuum," said Tony Titus, vice president of marketing for Cardiac Science. "Our HeartCentrix-Intergy integration gives our customers leading-edge capabilities to meet these demands."

"Cardiac Science is a leader in ECG, Holter, cardiac stress, and automated external defibrillator sales into the physician office," noted Maureen Peszko, Senior Vice President, General Manager, Sage Software Healthcare, Inc. "Connecting to the existing Quinton Q-Stress cardiac stress systems, Burdick Atria ECG, Holter, and other devices they already have is another reason for physicians to confidently choose to work with Sage."

About Cardiac Science

Cardiac Science, a wholly owned subsidiary of Opto Circuits (India) Ltd., develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AED), electrocardiograph devices (ECG/EKG), cardiac stress treadmill and systems, PC-based diagnostic workstations, Holter monitoring systems, hospital defibrillators, vital signs monitors, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick^®, HeartCentrix^®, Powerheart^®, and Quinton^® brands, is headquartered in Bothell, Washington. With customers in almost 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.

Forward-Looking Statements

This press release contains forward-looking statements. The words "believe," "expect," "intend," "anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. Forward-looking statements in this press release include, but are not limited to, those relating to Cardiac Science Corporation's future AED sales in Japan, expected shipments of backordered products in the fourth quarter of 2010, and expectations regarding the closing of the transaction with Opto Circuits. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results and performance may vary significantly from those expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks include those more fully described in the Annual Report on Form 10-K filed by Cardiac Science Corporation for the year ended December 31, 2009, as updated by subsequent quarterly reports on Form 10-Q. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.

For updates and information on worldwide defibrillation and cardiac monitoring, find us on Facebook at http://facebook.com/cardiacscience, the Cardiac Science blog at http://www.cardiacscience.com/blog, Twitter at http://twitter.com/cardiacscience, and YouTube at http://budurl.com/CSonYT

For more information, contact (media) info@cardiacscience.com | (investors) ir@optoindia.com | +91.80.2852.8088